Editorial Board & Standards
Learn about our commitment to accurate, evidence-based peptide education and the standards that guide our content.
Our Mission
Peptide Authority exists to provide comprehensive, research-backed peptide education for the UK and EU audience. We aim to bridge the gap between complex scientific research and accessible public understanding, enabling informed decision-making while always emphasising the importance of professional medical guidance.
Editorial Standards
Evidence-Based Content
All information is derived from peer-reviewed research, clinical trials, and reputable medical literature. We prioritise human studies where available.
Balanced Reporting
We present both potential benefits and known risks. We do not exaggerate claims or promise outcomes that are not supported by evidence.
Accessible Language
Content is structured from plain English summaries for general readers to detailed mechanisms for researchers and practitioners.
Regular Updates
Content is reviewed and updated regularly to reflect new research findings and regulatory changes.
Our Editorial Board
SMDr Sarah Mitchell, PhDPharmacology and Peptide TherapeuticsKing's College London
Dr Mitchell holds a PhD in Pharmacology from King's College London and has spent over 15 years researching peptide mechanisms of action and drug delivery systems. She leads our content review process for all peptide profiles and mechanism articles, ensuring pharmacology claims are grounded in published evidence.
PhD Pharmacology, FHEA
Full profile, registrations, conflicts & sections reviewed
JHDr James Harrington, MBChB, MRCPClinical EndocrinologyNHS England (consultant endocrinologist)
Dr Harrington is a consultant endocrinologist with clinical experience in GLP-1 agonist prescribing and growth hormone disorders. He reviews our clinical content, ensuring accuracy in dosing information, side effect profiles, and UK regulatory context.
MBChB, MRCP, GMC Registered
Full profile, registrations, conflicts & sections reviewed
EKDr Elena Kowalski, MSc, PhDMolecular Biology and ImmunologyImperial College London
Dr Kowalski specialises in immune peptide research, with publications on thymosin alpha-1 and antimicrobial peptides. She reviews our immunology content and ensures our safety information reflects current research.
MSc, PhD Molecular Biology
Full profile, registrations, conflicts & sections reviewed
DCDr David Chen, PharmDClinical Pharmacy and Regulatory AffairsFormer MHRA Advisory Panel; current independent practice
Dr Chen brings expertise in UK pharmaceutical regulation, having served on an MHRA advisory panel on peptide classification. He reviews our regulatory content, patient-education guides, and ensures compliance with UK advertising standards.
PharmD, MRPharmS, GPhC Registered
Full profile, registrations, conflicts & sections reviewed
Content Review Process
Research & Sourcing
Content is researched using primary scientific literature, with priority given to peer-reviewed journals and official regulatory sources.
Expert Review
All content is reviewed for scientific accuracy, balanced presentation, and appropriate caveats regarding research limitations.
Editorial Approval
Final review ensures content meets our editorial standards, includes appropriate disclaimers, and is accessible to our diverse audience.
Ongoing Monitoring
Published content is monitored for accuracy and updated when new research or regulatory changes require revision.
Affiliate Disclosure
Peptide Authority may receive compensation when visitors purchase products through our partner links, including Peptide Barn. This does not influence our editorial content, which is created independently based on research evidence. Our primary commitment is to educational accuracy and user safety.